Kiribati vs Sao Tome and Principe: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Kiribati
0.9%
in 2024
Sao Tome and Principe
0.8%
in 2024
Kiribati rank
40th
Sao Tome and Principe rank
44th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Kiribati
- Sao Tome and Principe
How they compare
Kiribati currently reports 0.9% against 0.8% in Sao Tome and Principe, a difference of 0.1%.
That makes Kiribati's figure about 1.1 times Sao Tome and Principe's.
Across all 10 years both countries report, Kiribati has been ahead every year.
Kiribati ranks 40th and Sao Tome and Principe ranks 44th of 246 countries.
Kiribati has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kiribati | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.9% | 0.9% | 1.0% | Kiribati |
| 2020s | 1.1% | 0.8% | 0.3% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Kiribati or Sao Tome and Principe?
- Kiribati, at 0.9% against 0.8% in Sao Tome and Principe as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Kiribati and Sao Tome and Principe?
- 0.1%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Sao Tome and Principe?
- 10 years are reported by both, from 2015 to 2024.
- How do Kiribati and Sao Tome and Principe rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Kiribati ranks 40th and Sao Tome and Principe ranks 44th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.